Professional Documents
Culture Documents
What is endometriosis?
Endometriosis is a common cause of chronic pelvic pain in women and is also associated with infertility. Characterized by the presence of endometrial tissue (Endometrial cells are the same cells that are shed each month during menstruation) outside the uterus, endometriosis is a chronic, recurring disease. Therapy is targeted at relieving symptoms and improving fertility.
The cells of endometriosis attach themselves to tissue outside the uterus and are called endometriosis implants. These implants are most commonly found on the ovaries, the Fallopian tubes, outer surfaces of the uterus or intestines, and on the surface lining of the pelvic cavity.
They can also be found in the vagina, cervix, and bladder, although less commonly than other locations in the pelvis. Rarely, endometriosis implants can occur outside the pelvis, on the liver, in old surgery scars, and even in or around the lung or brain. Endometrial implants, while they can cause problems, are benign (not cancerous)
While most cases of endometriosis are diagnosed in women aged around 25-35 years, endometriosis has been reported in girls as young as 11 years of age. Endometriosis is rare in postmenopausal women. Endometriosis is more commonly found in white women as compared with African American and Asian women. Studies further suggest that endometriosis is most common in taller, thin women with a low body mass index (BMI). Delaying pregnancy until an older age is also believed to increase the risk of developing endometriosis.
Another possibility is that areas lining the pelvic organs possess primitive cells that are able to grow into other forms of tissue, such as endometrial cells. (This process is termed coelomic metaplasia.)
It is also likely that direct transfer of endometrial tissues during surgery may be responsible for the endometriosis implants sometimes seen in surgical scars (for example, episiotomy or Cesarean section scars). Transfer of endometrial cells via the bloodstream or lymphatic system is the most likely explanation for the rare cases of endometriosis that develop in the brain and other organs distant from the pelvis.
Finally, some studies have shown alternations in the immune response in women with endometriosis, which may affect the body's natural ability to recognize and destroy any misdirected growth of endometrial tissue.
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Some women experience pain or cramping with intercourse, bowel movements and/or urination. Even pelvic examination by a doctor can be painful. The pain intensity can change from month to month, and vary greatly among women. Some women experience progressive worsening of symptoms, while others can have resolution of pain without treatment.
Pelvic pain in women with endometriosis depends partly on where the implants of endometriosis are located. Deeper implants and implants in areas with many painsensing nerves may be more likely to produce pain. The implants may also produce substances that circulate in the bloodstream and cause pain.
Other symptoms related to endometriosis include: lower abdominal pain, diarrhea and/or constipation, low back pain, irregular or heavy menstrual bleeding, or blood in the urine.
Rare symptoms of endometriosis include chest pain or coughing blood due to endometriosis in the lungs and headache and/or seizures due to endometriosis in the brain.
Unfortunately, neither the symptoms nor the physical examinations can be relied upon to conclusively establish the diagnosis of endometriosis. Imaging studies, such as ultrasound, can be helpful in ruling out other pelvic diseases and may suggest the presence of endometriosis in the vaginal and bladder areas, but still cannot definitively diagnose endometriosis. For an accurate diagnosis, a direct visual inspection inside of the pelvis and abdomen, as well as tissue biopsy of the implants are necessary.
As a result, the only accurate way of diagnosing endometriosis is at the time of surgery, either by opening the belly with large-incision laparotomy or smallincision laparoscopy.
Since endometriosis occurs during the reproductive years, many of the available medical treatments for endometriosis rely on interruption of the normal cyclical hormone production by the ovaries. These medications include GnRH analogs, oral contraceptive pills, and progestins.
Gonadotropin-releasing hormone analogs (GnRH analogs) Gonadotropin-releasing hormone analogs (GnRH analogs) have been effectively used to relieve pain and reduce the size of endometriosis implants. These drugs suppress estrogen production by the ovaries by inhibiting the secretion of regulatory hormones from the pituitary gland. As a result, menstrual periods stop, mimicking menopause. Nasal and injection forms of GnRH agonists are available.
The side effects are a result of the lack of estrogen, and include:
hot flashes, vaginal dryness, irregular vaginal bleeding, mood changes, fatigue, and loss of bone density (osteoporosis). Fortunately, by adding back small amounts of estrogen and progesterone in pill form (similar to treatments sometimes used for symptom relief in menopause) many of the annoying side effects due to estrogen deficiency can be avoided. "Add back therapy" is the term that refers to this modern way of administering GnRH agonists along with estrogen and progesterone in a way to keep the treatment successful, but avoid most of the unwanted side effects.
Oral contraceptive pills (estrogen and progesterone in combination) are also sometimes used to treat endometriosis. The most common combination used is in the form of the oral contraceptive pill (OCP). Sometimes women who have severe menstrual pain are asked to take the OCP continuously, meaning skipping the placebo (sugar pill) portion of the cycle. Continuous use in this manner will free a woman of having any menstrual periods at all. Occasionally, weight gain, breast tenderness, nausea, and irregular bleeding are mild side effects. Oral contraceptive pills are usually well-tolerated in women with endometriosis.
Progestins
Progestins [for example, medroxyprogesterone acetate (Provera, Cycrin, Amen), norethindrone acetate, norgestrel acetate (Ovrette)] are more potent than birth control pills and are recommended for women who do not obtain pain relief from or cannot take a birth control pill. Side effects are more common and include: breast tenderness, bloating, weight gain, irregular uterine bleeding, and depression. Since the absence of menstruation (amenorrhea) induced by high doses of progestins can last many months after cessation of therapy, these drugs are not recommended for women planning pregnancy.
Danazol (Danocrine) Danazol (Danocrine) is a synthetic drug that creates a high androgen (male type hormone) and low estrogen hormonal environment by interfering with ovulation and ovarian production of estrogen. Eighty percent of women who take this drug will have pain relief and shrinkage of endometriosis implants, but up to 75% of women develop side effects from the drug.
All of these changes are reversible, except for voice changes; but the return to normal may take many months. Danazol should not be taken by women with certain types of liver, kidney, and heart conditions
Aromatase inhibitors
A newer approach to the treatment of endometriosis has involved the adminis tration of drugs known as aromatase inhibi tors [for example, anastrozole (Arimidex) and letrozole (Femara)]. These drugs act by interrupting local estrogen formation with in the endometriosis implants themselves. They also inhibit estrogen production in the ovary, brain, and other sources, such as adipose tissue.
Medical Treatment
Progestin Ovary
Estrogen
Endometriosis Tissue
Estrogen
Estrogen
Cell growth
Aromatase
Estrogen
Cell growth
PGE2 Cytokines
Aromatase
Estrogen
Cell growth
Aromatase In Endometriosis
Aromatase is key for the biosynthesis of estrogen In patients aromatase expression is higher in endometriosis tissue than in normal endometrium In endometriosis tissue aromatase activity is stimulated by prostaglandin Estrogen synthesized by endometriotic tissue stimulates growth of lesions
Aromatase
Estrogen
Cell growth
Aromatase
Estrogen
Cell growth
Research is still ongoing to characterize the effectiveness of aromatase inhibitors in the management of endometriosis. Aromatase inhibitors cause significant bone loss with prolonged use and cannot be used alone without other medications in premenopausal women because they stimulate development of multiple follicles at ovulation
Endometriosis At A Glance
Endometriosis is the growth of endometrial tissue but in a location outside of the uterus. Endometriosis is most commonly found on other organs of the pelvis. The exact cause of endometriosis has not been identified.
Endometriosis is more common in women who are experiencing infertility than in fertile women, but the condition does not fully prevent conception. Pelvic pain during menstruation or ovulation can be a symptom of endometriosis, but may also occur in normal women.
Treatment of endometriosis includes medication and surgery for both pain relief and treatment of infertility if pregnancy is desired.